AbbVie Inc. (ABBV): director Dr. John M. Carethers elected to the board

Events in this filing

Item 5.02 as filed

Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers
On October 14, 2026, AbbVie Inc. (“AbbVie”) expanded
the size of its Board of Directors (the “Board”) from twelve directors to thirteen directors and appointed Dr. John M.
Carethers as a Class II director. Dr. Carethers currently serves as the Vice Chancellor for Health Sciences at the University
of California San Diego and was previously a director of Avantor, Inc. Dr. Carethers has been appointed to the Public Policy
and Sustainability Committee of AbbVie. The Board affirmatively determined that Dr. Carethers is an “independent director”
under each of the standards set forth in section 303A.02 of the New York Stock Exchange Listed Company Manual and AbbVie’s Governance
Guidelines and Director Independence Guidelines. Dr. Carethers will be entitled to compensation as an independent director as
disclosed in Exhibit 10.5 to AbbVie’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025.